Suchergebnisse

Exhortation addressed to the Mexican Army, urging its members to emulate the heroic deeds and virtues of such military figures as Antonio Quiroga and Rafael del Riego

Anti-clerical discussion of the church and monarchy, advocating the creation of a new secular clergy and the extinction of religious orders

The extent of mitochondrial DNA divergence between populations of the
vulnerable yellow-footed rock- wallaby,
Petrogale xanthopus, was assessed by restriction
analysis. Of the 15 restriction endonucleases, five were informative, with a
single unique haplotype identified in P. x. celeris from
Queensland (Qld) (n = 8) and a further two unique
haplotypes in three sampled populations of
P. x. xanthopus from New South Wales (NSW)
(n = 1) and South Australia (SA)
(n = 9). The two subspecies of
P. xanthopus were found to be genetically distinct
(average sequence divergence = 0·72%). As this divergence
is greater than that found between some Petrogale
species, it is recommended that populations of
P. x. xanthopus and P. x. celeris
be managed independently both in captivity and the wild. The NSW population of
P. x. xanthopus appears genetically similar to those in
SA, although these data are limited.

Introduction and objective: The regulation of pharmacy preparations, especially for standards for quality assurance and safety, is not harmonised across Europe and falls under the national competencies of individual states. There are concerns about quality control and safety for the medicinal products made in pharmacies, which is widespread in European countries. There are, however, good reasons to continue this practice, which is able to tailor preparations to the specific needs of a particular patient or patient group and to provide a supplementary source of supply when an industrially manufactured product, which is authorised for marketing is not available or when there are temporary shortages of licensed medicines. In seeking to provide guidelines for legislation and acting on the advice of an expert group dealing in pharmaceutical practices, the Committee of Ministers of the Council of Europe passed a resolution in 2011. The Council of Europe Resolution provides authorities and pharmacists with the means to reinforce safety measures for medicinal products prepared in pharmacies and to harmonise quality assurance and safety standards. It dealt with aspects of pharmacy preparation such as quality standards for preparation and distribution, marketing authorisation, product dossiers, labelling, reporting, and safety. In 2013 and 2014 the Committee of Experts carried out a survey to evaluate the impact of the resolution within a cross section of member states,Methods: In the resolution of 2011 the member states were recommended to adapt their legislation in line with its provisions. The survey that was carried out in 2013 and 2014 followed the recommendations in the reso-lution. A questionnaire was made and sent to across section of member states.Results: Among the member states involved, the results of this survey show a clear commitment to imple-ment the recommendations of the resolution.Conclusions: This report presents the results of the survey with a discussion of outstanding issues.